WallStreetZenWallStreetZen

NYSEMKT: NNVC
Nanoviricides Inc Earnings & Revenue

NNVC earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$9.5M
Current Profit Margin
0%

NNVC Return on Equity

Current Company
-74.7%
Current Industry
16.8%
Current Market
28.2%
NNVC's Return on Equity (-74.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when NNVC announces earnings.

NNVC Return on Assets

Current Company
-66.5%
Current Industry
3.2%
NNVC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NNVC Return on Capital Employed

Current Company
-88.8%
Current Industry
-42.4%
NNVC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NNVC vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NNVC$0.00-$8.70M-$9.51MN/AN/A
NERV$0.00-$31.57M-$31.60M-100.00%N/A
PHGE$0.00-$33.55M-$37.14MN/AN/A
APRE$963.80k-$13.96M-$12.72MN/AN/A
SPRB$10.13M-$47.11M-$46.75M+415.63%N/A

Nanoviricides Earnings & Revenue FAQ

What were NNVC's earnings last quarter?

On Invalid Date, Nanoviricides (NYSEMKT: NNVC) reported Q1 2024 earnings per share (EPS) of -$0.16, up 6.67% year over year. Total Nanoviricides earnings for the quarter were -$1.85 million. In the same quarter last year, Nanoviricides's earnings per share (EPS) was -$0.15.

If you're new to stock investing, here's how to buy Nanoviricides stock.

What was NNVC's earnings growth in the past year?

As of Q2 2024, Nanoviricides's earnings has grown year over year. Nanoviricides's earnings in the past year totalled -$9.51 million.

What was NNVC's revenue last quarter?

On Invalid Date, Nanoviricides (NYSEMKT: NNVC) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Nanoviricides's revenue was $0.00.

What was NNVC's revenue growth in the past year?

As of Q2 2024, Nanoviricides's revenue has grown null year over year. Nanoviricides's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.